NAUTILUS BIOTECHNOLOGY

Nautilus Biotechnology Reports Second Quarter 2023 Financial Results

02 Aug 2023 06:30:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023

11 Jul 2023 08:23:03 By Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in Upcoming June Investor Conferences

24 May 2023 07:05:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology Reports First Quarter 2023 Financial Results

02 May 2023 05:30:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023

18 Apr 2023 15:05:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference

23 Mar 2023 07:00:01 By Nasdaq GlobeNewswire

Nautilus Biotechnology Announces “First Access Challenge” Winners

07 Mar 2023 07:00:01 By Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results

23 Feb 2023 05:05:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference

21 Feb 2023 07:00:02 By Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

26 Jan 2023 07:00:01 By Nasdaq GlobeNewswire

Nautilus Biotechnology Expands to San Diego

26 Jan 2023 06:45:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)

19 Jan 2023 07:00:01 By Nasdaq GlobeNewswire

Nautilus Biotechnology Launches “First Access Challenge”

16 Nov 2022 07:00:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Third Quarter 2022 Financial Results

01 Nov 2022 05:05:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022

05 Oct 2022 07:00:02 By Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit

23 Sep 2022 07:00:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology Joins Human Proteome Organization (HUPO) Industrial Advisory Board

01 Sep 2022 07:00:01 By Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference

30 Aug 2022 07:00:01 By Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Second Quarter 2022 Financial Results

02 Aug 2022 05:48:06 By Nasdaq GlobeNewswire

Nautilus Biotechnology Appoints Eric Spence as Vice President of Instrument Engineering and Ken Kuhn, Ph.D., as Vice President of Reagent and Platform Development

01 Aug 2022 15:05:00 By Nasdaq GlobeNewswire